BT173 is a novel small molecule inhibitor targeting Homeodomain-Interacting Protein Kinase 2 (HIPK2). It attenuates renal fibrosis by suppressing the TGF-beta1/Smad3 signaling pathway, as demonstrated in relevant in vitro and in vivo fibrosis research models.
Molecular Weight:
382.21
Purity:
98.24% (May vary between batches)
CAS Number:
[2232180-74-2]
Formula:
C18H12BrN3O2
Target:
DYRK,Others
Application Notes:
Solubility: DMSO:Insoluble
* VAT and and shipping costs not included. Errors and price changes excepted